Literature DB >> 3203458

Topical nasopharyngeal anaesthesia with vasoconstriction in preeclampsia-eclampsia.

B K Mokriski1, A M Malinow, W C Gray, W J McGuinn.   

Abstract

We report the case of a 38-year-old eclamptic patient undergoing emergency Caesarean section who required awake nasotracheal intubation because of her massively swollen and lacerated tongue. Vasoconstriction, in addition to topical anaesthesia, was required due to thrombocytopaenia. The use of three per cent lidocaine with 0.125 per cent phenylephrine for anaesthesia and vasoconstriction is described with successful maternal and neonatal outcome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203458     DOI: 10.1007/BF03020355

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  6 in total

1.  Effect of cocaine on uterine blood flow and fetal oxygenation.

Authors:  J R Woods; M A Plessinger; K E Clark
Journal:  JAMA       Date:  1987-02-20       Impact factor: 56.272

2.  Blood pressure and heart rate changes during awake fiberoptic nasotracheal intubation.

Authors:  A Ovassapian; S J Yelich; M H Dykes; E E Brunner
Journal:  Anesth Analg       Date:  1983-10       Impact factor: 5.108

3.  A suitable substitute for 4% cocaine before blind nasotracheal intubation: 3% lidocaine-0.25% phenylephrine nasal spray.

Authors:  J B Gross; M L Hartigan; D W Schaffer
Journal:  Anesth Analg       Date:  1984-10       Impact factor: 5.108

4.  Systemic and pulmonary blood pressure during caesarean section in parturients with gestational hypertension.

Authors:  R Hodgkinson; F J Husain; R H Hayashi
Journal:  Can Anaesth Soc J       Date:  1980-07

5.  Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus.

Authors:  T R Moore; J Sorg; L Miller; T C Key; R Resnik
Journal:  Am J Obstet Gynecol       Date:  1986-10       Impact factor: 8.661

6.  Intranasal and oral cocaine kinetics.

Authors:  P Wilkinson; C Van Dyke; P Jatlow; P Barash; R Byck
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.